Stay updated on KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.

Latest updates to the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s revision history now includes a new entry showing the update from v3.5.3 to v3.5.4. This represents a small interface or backend update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe ClinicalTrials.gov page’s revision/version indicator was updated from v3.5.2 to v3.5.3 in the footer.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed in the version history.SummaryDifference0.1%

- Check60 days agoChange DetectedSponsor line updated to Karuna Therapeutics, Inc., a Bristol Myers Squibb company.SummaryDifference0.2%

- Check75 days agoChange DetectedAdded a new revision entry v3.5.0 and removed the previous v3.4.3 entry from the Study Record Versions.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.1%

Stay in the know with updates to KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Efficacy in Acutely Psychotic Schizophrenia Clinical Trial page.